Showing results (1141-1150 of 1,637) with videos related to

Sort By:
Pageof 164
Eclinicalmedicine|March 7, 2022
Traumatic brain injury in precariously housed persons: Incidence and risksTiffany A O'Connor, William J Panenka, Emily M Livingston, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 21, 2018
Interaction Between Pannexin 1 and Caveolin-1 in Smooth Muscle Can Regulate Blood PressureLeon J DeLalio, Alexander S Keller, Jiwang Chen, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacementsPaul J Coleman, Karen M Brashear, Cecilia A Hunt, et al.
Journal of the American College of Cardiology|June 16, 2018
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve ReplacementJohn D Puskas, Marc Gerdisch, Dennis Nichols, et al.
Global Change Biology|March 7, 2025
Postglacial Recolonization of the Southern Ocean by Elephant Seals Occurred From Multiple Glacial RefugiaAndrew A Berg, Megan Askew, Frederik V Seersholm, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammationJian Jeffrey Chen, Thomas Nguyen, Derin C D'Amico, et al.
Nature|December 14, 2022
Microglia regulate central nervous system myelin growth and integrityNiamh B McNamara, David A D Munro, Nadine Bestard-Cuche, et al.
American Journal of Human Genetics|June 21, 2002
CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafnessL M Astuto, J M Bork, M D Weston, et al.
Journal of Medicinal Chemistry|January 25, 2007
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activityDerin C D'Amico, Toshi Aya, Jason Human, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitorsJeffrey A Pfefferkorn, Yuntao Song, Kuai-Lin Sun, et al.
Pageof 164